<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In general, 
 <italic class="italic">Curcuma</italic> EOs are nontoxic, nonmutagenic, noncarcinogenic and nonphototoxic [
 <xref rid="B125-nutrients-10-01196" ref-type="bibr" class="xref">125</xref>,
 <xref rid="B239-nutrients-10-01196" ref-type="bibr" class="xref">239</xref>]. Turmeric EO has been classified as generally recognized as safe (GRAS) [
 <xref rid="B125-nutrients-10-01196" ref-type="bibr" class="xref">125</xref>]. Undiluted turmeric rhizome oil was slightly irritating to rabbits, but was not irritating to mice. When tested at 4% on 25 volunteers, it was neither irritating nor sensitizing [
 <xref rid="B239-nutrients-10-01196" ref-type="bibr" class="xref">239</xref>]. There is a possible drug interaction when used orally, especially with antidiabetic medications [
 <xref rid="B125-nutrients-10-01196" ref-type="bibr" class="xref">125</xref>]. The acute dermal LD
 <sub class="sub">50</sub> of turmeric rhizome oil was &gt;5 g/kg in rabbits, and the acute oral LD
 <sub class="sub">50</sub> was &gt;5 g/kg in rats [
 <xref rid="B239-nutrients-10-01196" ref-type="bibr" class="xref">239</xref>]. When administered intraperitoneally (i.p.) at doses higher than 28 mg/kg/day, 20–36% of normal and streptococcal cell wall-injected animals died after two weeks of treatment, while lower vehicle or oil doses (≤2.8 mg/kg/day) caused no deaths [
 <xref rid="B182-nutrients-10-01196" ref-type="bibr" class="xref">182</xref>]. Oral administration of a dose of turmeric oil that is 20-fold higher than the lowest effective i.p. doses was nontoxic [
 <xref rid="B182-nutrients-10-01196" ref-type="bibr" class="xref">182</xref>]. No hazards or adverse skin reactions were reported for turmeric-leaf EO; however, the α-phellandrene chemotype might cause skin sensitization on oxidation.
</p>
